Illinois Administrative Code

Section 641.40 Policies and Procedures a) At a minimum the Center must have the following written policies set forth and in place: 1) Non-discrimination, confidentiality, parental consent, student rights/responsibilities, release of information, conflict of interest/disclosure, e…

Section 641.5 Purpose a) The requirements set forth in this Part establish criteria for certification of School-Based/Linked Health Centers (Center). b) These requirements shall be used by the Department for certification, re-certification, and periodic inspection of Centers. Per…

Section 641.50 Compliance Standards a) All medical services must be in compliance with the standards set by the American College of Obstetricians and Gynecologists (ACOG), 1985, 409 12th Street S.W., Washington DC 20024-2188, American Academy of Pediatrics (AAP), 1988, 141 Northw…

Section 641.60 Scope of Services The Center provides comprehensive primary and preventive physical, mental health, and health education services for children and adolescents within the context of their family, social/emotional, cultural, physical and educational environment. Some…

Section 641.70 Staffing Standards The Center must deliver care to students by Illinois licensed, registered and/or certified health professionals who are trained and experienced in community and school health, and who have knowledge of health promotion and illness prevention stra…

Section 641.80 Access Standards The Center must establish procedures for the availability of primary care providers and for access to routine, urgent and emergency care, telephone appointments and advice. a) Availability of Services 1) The Center operations must ensure that: A) t…

Section 641.90 Student Identification The Center must develop a collaborative relationship with other health care providers, insurers, managed care entities, the school health program, students and parents/guardians with the goal of reducing duplication of services, fragmentation…

Section 655.10 General Considerations a) For some, pregnancy can present social, emotional, financial and/or health problems. A wide array of services which can assist women who have problem pregnancies is not available in all communities, and in communities where such services a…

Section 655.20 Policies a) Content of Projects 1) Projects shall be directed toward the provision and coordination of services which assist women with problem pregnancies or women at risk of initial or repeat problem pregnancies in accordance with accepted maternal and child heal…

Section 655.30 Standards a) Comprehensiveness Provisions shall be made for the development of a care plan for each client that assures effective interdisciplinary provision of comprehensive services. Comprehensive means completeness to ensure that all needed services are availabl…

Section 655.40 Use of Project Funds a) 1) When approved in the plan and budget, funds may be used for the direct costs of operating and maintaining the project. 2) The following direct costs may be incurred: A) Salaries, including fringe benefits, for full or part-time profession…

Section 655.50 Application Content and Process a) Applications for grants under this authority shall be made in the format specified in the "Application and Plan for Health Services Grant" (Form EBA 1, available from the Department of Public Health, 535 West Jefferson, Springfiel…

Section 655.60 General Requirements a) Grantees may charge fees for services paid with funds under this authority, but only pursuant to an approved fee schedule which bases fees charged by the grantee on the family size and the income of the service recipients, and an assurance t…

Section 657.10 Definition of Maternal Death Maternal Death is the death of any woman dying of any cause whatsoever while pregnant or within one year after the termination of the pregnancy, irrespective of the duration of the pregnancy at the time of the termination or the method …

Section 657.20 Reporting of Maternal Death In the event of a maternal death and when requested in writing by the Illinois Department of Public Health, any hospital, any coroner or medical examiner, or any health care provider, having contact with the deceased, shall provide one c…

Section 657.30 Time Limit on Reporting The medical records and autopsy report pertinent to the maternal death shall be provided to the Department within 30 days after receipt, by the hospital, coroner, medical examiner, or health care provider, of the Department's written request…

Section 657.40 Confidentiality of Records The Department of Public Health will keep all records confidential pursuant to federal law, Part 21 of Article VIII of the Code of Civil Procedure [735 ILCS 5/Art. VIII, Part 21], and Section 5 of the Illinois Health Statistics Act [410 I…

Section 661.10 Definitions "Adrenoleukodystrophy" or "ALD" means a rare inborn disorder that affects the brain, nervous system, and adrenal glands because the body cannot break down certain fatty acids. "Advanced practice registered nurse" means a person who is licensed as an adv…

Section 661.100 Newborn Screening Registries The Department shall maintain a Newborn Screening Registry or Registries to collect, store, analyze, release, and report newborn blood spot, newborn hearing and newborn heart screening data including the results of diagnosis and treatm…

Section 661.110 Early Hearing Detection and Intervention (EHDI) Registry a) The Department will maintain a registry of cases. The Department will maintain a registry documenting screening, diagnosis, and intervention of cases of positive hearing screening results, including infor…

Section 661.120 Confidentiality and Access to Data in Newborn Screening Registries a) The Department will maintain confidentiality of information that would identify individual patients. All data in the Registry or Registries obtained directly from medical, intervention or parent…

Section 661.130 Data Submission a) The Registry shall be accessible to authorized users for the submission of information related to newborn blood spot, newborn hearing and newborn heart screening. Both demographic and newborn blood spot, newborn hearing and newborn heart screeni…

Section 661.140 Provider Sites a) As a condition of enrollment in the Registry, the authorized user site shall enter into and agree to comply with an authorized user agreement with the Department and shall agree to use the Registry only for the confirmation of compliance with scr…

Section 661.150 Individual User Agreement a) Each employee of an authorized user site who needs access to a Registry shall sign an individual authorized user agreement, which also includes a confidentiality statement. Patient-specific or provider-specific information is available…

Section 661.20 Incorporated and Referenced Materials a) The following federal and State statutes and rules guidelines are referenced in this Part: 1) Illinois Statutes: A) Newborn Metabolic Screening Act [410 ILCS 240] B) Early Hearing Detection and Intervention Act [410 ILCS 213…

Section 661.200 Collection and Submission of Specimens a) All blood spot samples collected pursuant to this Part shall be submitted for testing to the laboratory designated by the Department. b) When a retest blood spot sample is determined to be necessary pursuant to Subpart C o…

Section 661.210 Blood Spot Reporting Any medical care facility or health care provider submitting newborn screening specimens to the Illinois Department of Public Health Laboratory shall comply with all requirements of this Part, and shall notify the Department immediately whenev…

Section 661.220 Retention of Specimens a) Blood spot samples received by the Department for newborn screening will be retained for a minimum of two months. b) If all test results obtained from a blood spot sample are determined to be within normal range, the sample will be retain…

Section 661.230 Designation of Medical Specialists The Department, with the advice of the University of Illinois Division of Specialized Care for Children, and with the recommendation of the Advisory Committee, will designate consultants qualified to diagnose a condition detected…

Section 661.30 General Procedures for the Newborn Screening a) Pursuant to the Newborn Metabolic Screening Act [410 ILCS 240], the physician in attendance at or immediately after the birth of the newborn shall have primary responsibility for seeing that a newborn is screened in a…

Section 661.300 Adrenoleukodystrophy (ALD) a) Interpretation of Results. Although the majority of infants affected by ALD will be identified by this screening, due to genetic variabilities and variations in health status, specimen quality, and timing of specimen collection, not a…

Section 661.310 Biotinidase Deficiency a) Interpretation of Results. Although the majority of infants affected by biotinidase deficiency will be identified by this screening, due to genetic variabilities and variations in health status, specimen quality, and timing of specimen co…

Section 661.320 Congenital Adrenal Hyperplasia (CAH) (Secondary to 21-hydroxylase deficiency) a) Interpretation of Results. Although the majority of infants affected by CAH will be identified by this screening, due to genetic variabilities and variations in health status, specime…

Section 661.330 Congenital Hypothyroidism (CH) a) Interpretation of Results. Although the majority of infants affected by CH will be identified by this screening, due to genetic variabilities and variations in health status, specimen quality, and timing of specimen collection, no…

Section 661.340 Cystic Fibrosis (CF) a) Interpretation of Results. Although the majority of infants affected by CF will be identified by this screening, due to genetic variabilities and variations in health status, specimen quality, and timing of specimen collection, not all infa…

Section 661.350 Galactosemia a) Interpretation of Results. Although the majority of infants affected by galactosemia will be identified by this screening, due to genetic variabilities and variations in health status, specimen quality, and timing of specimen collection, not all in…

Section 661.360 Lysosomal Storage Disorders (LSDs) a) Interpretation of Results. Although the majority of infants affected by an LSD will be identified by this screening, due to genetic variabilities and variations in health status, specimen quality, and timing of specimen collec…

Section 661.370 Amino Acid, Organic Acid and Fatty Acid Oxidation Disorders a) Interpretation of Results. Although the majority of infants affected by amino acid, organic acid and fatty acid oxidation disorders will be identified by this screening, due to genetic variabilities an…

Section 661.380 Severe Combined Immunodeficiency (SCID) and T-Cell Lymphopenia a) Interpretation of Results. Although the majority of infants affected by SCID or T-cell lymphopenia will be identified by this screening, due to genetic variabilities and variations in health status,…

Section 661.390 Sickle Cell Disease/Trait and Other Hemoglobinopathies a) Interpretation of Results. Although the majority of infants affected by sickle cell disease/trait and other hemoglobinopathies will be identified by this screening, due to genetic variabilities and variatio…

Section 661.40 Genetic and Metabolic Diseases Advisory Board a) The Director shall create the Genetic and Metabolic Diseases Advisory Committee to advise the Department regarding issues relevant to newborn screenings of metabolic diseases and other newborn non-metabolic condition…

Section 661.400 Spinal Muscular Atrophy (SMA) a) Interpretation of Results. Although the majority of infants affected by SMA will be identified by this screening, due to genetic variabilities and variations in health status, sample quality, and timing of sample collection, not al…

Section 661.50 Exemption Whenever a newborn screening test is not performed because a parent or legal guardian objects on the grounds that such test conflicts with their religious tenets and practices, a written statement of such objection shall be presented to the physician or o…

Section 661.500 Critical Congenital Heart Disease (CCHD) a) All newborns, including those in the neonatal intensive care unit, special care baby unit, and birth centers, shall receive pulse oximetry screening for critical congenital heart disease after 24 hours of age or before m…

Section 661.599 Newborn Hearing Screening Program Goals a) All infants born in Illinois will have their hearing screened prior to discharge from the hospital that performed the delivery, or no later than one month of age, whichever comes first. b) All newborns referred from the I…

Section 661.60 Fee Assessment and Payment a) Each institution or person submitting to the Department any sample for newborn screening shall be assessed a fee of $411.35. b) Monthly Statements of fee assessment shall be mailed to facilities submitting samples for analysis. c) Paym…

Section 661.600 Newborn Hearing Screening a) Each medical care facility shall conduct bilateral hearing screening of each newborn infant, including newborns and infants in a NICU or SBCU, prior to discharge unless medically contraindicated or the infant is transferred to another …